ICD-10-CM Code T80.89XA

Other complications following infusion, transfusion and therapeutic injection, initial encounter

Version 2020 Billable Code

Valid for Submission

T80.89XA is a billable code used to specify a medical diagnosis of other complications following infusion, transfusion and therapeutic injection, initial encounter. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code T80.89XA might also be used to specify conditions or terms like abdominal hernia as complication of peritoneal dialysis, acute disorder of hemodialysis, acute disorder of hemodialysis, acute disorder of hemodialysis, acute megaloblastic anemia, acute megaloblastic anemia, etc

ICD-10:T80.89XA
Short Description:Oth comp fol infusion, transfuse and theraputc inject, init
Long Description:Other complications following infusion, transfusion and therapeutic injection, initial encounter

Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Abdominal hernia as complication of peritoneal dialysis
  • Acute disorder of hemodialysis
  • Acute disorder of hemodialysis
  • Acute disorder of hemodialysis
  • Acute megaloblastic anemia
  • Acute megaloblastic anemia
  • Acute megaloblastic anemia due to dialysis
  • Acute megaloblastic anemia secondary to total parenteral nutrition
  • Adynamic bone disease
  • Air in infusion or transfusion due to mechanical failure of apparatus
  • Allergic transfusion reaction
  • Alloimmune platelet transfusion refractoriness
  • Alloimmune thrombocytopenia
  • Anaphylactoid reaction to dialysis
  • Bloodstained peritoneal dialysis effluent
  • Complication of injection
  • Complication of introduction procedure
  • Dialysis dementia
  • Dialysis disequilibrium syndrome
  • Dialysis fluid adverse reaction
  • Dialysis membrane-induced anaphylactoid reaction
  • Dialysis-associated ascites
  • Dialysis-associated hypoxia
  • Encapsulating peritoneal sclerosis associated with peritoneal dialysis
  • Erythema at injection site
  • Erythrocytosis due to autotransfusion
  • Extravasation following blood transfusion
  • Extravasation injury
  • First use syndrome of dialysis
  • Hematoma of dialysis access site
  • Hemodialysis fluid adverse reaction
  • Hemodialysis-associated pruritus
  • Hemodialysis-associated pseudoporphyria
  • Hemofiltration solution adverse reaction
  • Hemolytic transfusion reaction
  • Hemoperitoneum as complication of peritoneal dialysis
  • Hemorrhage into peritoneal cavity
  • Hydrothorax
  • Hydrothorax as complication of peritoneal dialysis
  • Hypercalcemia associated with chronic dialysis
  • Hyperchloremic acidosis associated with dialysis
  • Iatrogenic neonatal hyperglycemia
  • Inadequate hemodialysis
  • Inadequate peritoneal dialysis
  • Induration at injection site
  • Injection neuropathy
  • Injection site anesthesia
  • Injection site atrophy
  • Injection site bruising
  • Injection site burning
  • Injection site cyst
  • Injection site dermatitis
  • Injection site edema
  • Injection site fibrosis
  • Injection site hemorrhage
  • Injection site hypersensitivity
  • Injection site induration
  • Injection site inflammation
  • Injection site irritation
  • Injection site malabsorption
  • Injection site mass
  • Injection site mass
  • Injection site necrosis
  • Injection site nerve damage
  • Injection site pain
  • Injection site paresthesia
  • Injection site pigmentation change
  • Injection site thrombosis
  • Injection site urticaria
  • Injury due to and following infusion
  • Injury due to and following therapeutic injection
  • Injury due to and following transfusion
  • Intestinal obstruction due to a procedure
  • Intravasation of drug or medicament
  • Lipoatrophy
  • Lipoatrophy due to injected drug
  • Lipogranuloma
  • Localized adverse reaction to administration of drug
  • Localized lipoatrophy
  • Long-term disorder of dialysis
  • Loss of solute clearance
  • Loss of ultrafiltration
  • Mechanical failure of instrument or apparatus during infusion or transfusion
  • Mechanical failure of instrument or apparatus during kidney dialysis
  • Megaloblastic anemia due to hemodialysis
  • Megaloblastic anemia due to hyperalimentation
  • Metabolic acidosis, NAG, acidifying salts
  • Neonatal hyperbilirubinemia following total parenteral nutrition
  • Neonatal hyperglycemia
  • Neonatal hyperglycemia due to iatrogenic intravenous therapy
  • Neonatal polycythemia
  • Nontraumatic hemoperitoneum
  • Osteonecrosis due to and following renal dialysis
  • Pain during inflow of dialysate
  • Pain during outflow of dialysate
  • Penile sclerosing lipogranuloma
  • Penile sclerosing lipogranuloma due to injected substance
  • Peritoneal dialysis solution adverse reaction
  • Polycythemia neonatorum following blood transfusion
  • Pseudoporphyria
  • Pulmonary transfusion reaction
  • Sclerosing lipogranuloma
  • Sclerosing peritonitis
  • Sclerosing peritonitis as complication of peritoneal dialysis
  • Skin lesion associated with hemodialysis
  • Skin lesion associated with hemodialysis
  • Swelling at injection site
  • Thrombocytopenia due to extracorporeal circulation of blood
  • Thromboembolism following infusion, perfusion AND/OR transfusion
  • Transfusion hemosiderosis
  • Transfusion reaction due to products of cell metabolism
  • Transfusion reaction due to toxic effect of anticoagulant
  • Transfusion reaction due to toxic substance in blood
  • Ultrafiltration failure
  • Underdialysis
  • Urticarial transfusion reaction

Convert T80.89XA to ICD-9

  • 999.88 - Infusion reaction NEC (Approximate Flag)
  • 999.89 - Transfusion reaction NEC (Approximate Flag)

Code Classification

  • Injury, poisoning and certain other consequences of external causes (S00–T98)
    • Complications of surgical and medical care, not elsewhere classified (T80-T88)
      • Comp following infusion, transfusion and theraputc injection (T80)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020